Göm menyn

Publications for Johan Rosell


Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 84 times*

Journal Articles

R. H. Dahlrot, J. Dowsett, S. Fosmark, Annika Malmström, R. Henriksson, H. Boldt, K. de Stricker, M. D. Sorensen, H. S. Poulsen, Malgorzata Lysiak, Peter Söderkvist, Johan Rosell, S. Hansen and B. W. Kristensen
  Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis
  Neuropathology and Applied Neurobiology, 2018, 44(2), 172-184.
 Web of Science® Times Cited: 2

Johan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per-Olof Malmstrom, Arne Wallgren, Olle Stål and John Carstensen
  Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen
  Acta Oncologica, 2017, 56(4), 614-617.
 Web of Science® Times Cited: 2

Annika Malmström, Hans Skovgaard Poulsen, Bjorn Henning Gronberg, Giuseppe Stragliotto, Steinbjorn Hansen, Thomas Asklund, Birgitta Holmlund, Malgorzata Lysiak, Joseph Dowsett, Bjarne Winther Kristensen, Peter Söderkvist, Johan Rosell and Roger Henriksson
  Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial
  Acta Oncologica, 2017, 56(12), 1776-1785.

Oliver Patschan, Sten Holmang, Abolfazl Hosseini, Georg Jancke, Fredrik Liedberg, Borje Ljungberg, Per-Uno Malmstrom, Johan Rosell and Staffan Jahnson
  Second-look resection for primary stage T1 bladder cancer: a population-based study
  Scandinavian journal of urology, 2017, 51(4), 301-307.

Vera Loorents, Johan Rosell, Helen Salgado Willner and Sussanne Börjeson
  Health-related quality of life up to 1 year after radiotherapy in patients with head and neck cancer (HNC)
  SpringerPlus, 2016, 5(1), .
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Kenney R. Roodakker, Tamador Elsir, Per-Henrik D. Edqvist, Daniel Hagerstrand, Joseph Carison, Malgorzata Lysiak, Roger Henriksson, Fredrik Ponten, Johan Rosell, Peter Söderkvist, Roger Stupp, Elena Tchougounova, Monica Nister, Annika Malmström and Anja Smits
  PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status
  OncoTarget, 2016, 7(45), 72431-72442.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Staffan Jahnson, Abolfazl Hosseini Aliabad, Sten Holmang, Georg Jancke, Fredrik Liedberg, Borje Ljungberg, Per-Uno Malmstrom and Johan Rosell
  Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment
  Scandinavian journal of urology, 2016, 50(1), 14-20.
 Web of Science® Times Cited: 3

Rami Klaff, Johan Rosell, Eberhard Varenhorst and Gabriel Sandblom
  The Long-term Disease-specific Mortality of Low-risk Localized Prostate Cancer: A Prospective Population-based Register Study Over Two Decades
  Urology, 2016, 91, 77-82.
 Web of Science® Times Cited: 2

Georg Jancke, Johan Rosell and Staffan Jahnson
  Tumour location adjacent to the ureteric orifice in primary Ta/T1 bladder cancer is predictive of recurrence
  Scandinavian journal of urology, 2016, 50(1), 33-38.
 Web of Science® Times Cited: 1

Firas Aljabery, Gunnar Lindblom, Susann Skoog, Ivan Shabo, Hans Olsson, Johan Rosell and Staffan Jahnson
  PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer.
  BMC urology, 2015, 15(1), 87.
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Oliver Patschan, Sten Holmang, Abolfazl Hosseini, Fredrik Liedberg, Borje Ljungberg, Per-Uno Malmstrom, Johan Rosell and Staffan Jahnson
  Use of bacillus Calmette-Guerin in stage T1 bladder cancer: Long-term observation of a population-based cohort
  Scandinavian journal of urology, 2015, 49(2), 127-132.
 Web of Science® Times Cited: 2

Georg Jancke, Johan Rosell and Staffan Jahnson
  Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer
  SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48(3), 276-283.
 Web of Science® Times Cited: 13

Vera Loorents, Johan Rosell, Charlott Karlsson, Maria Lidback, Kristina Hultman and Sussanne Börjeson
  Prophylactic training for the prevention of radiotherapy-induced trismus - a randomised study
  Acta Oncologica, 2014, 53(4), 530-538.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

Rune Sjödahl, Johan Rosell and Hans Starkhammar
  Causes of death after surgery for colon cancer-impact of other diseases, urgent admittance, and gender
  Scandinavian Journal of Gastroenterology, 2013, 48(10), 1160-1165.
 Web of Science® Times Cited: 1

Johan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per-Olof Malmstrom, Arne Wallgren, Olle Stål and John Carstensen
  Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
  Breast Cancer Research and Treatment, 2013, 138(2), 467-473.
 Web of Science® Times Cited: 7

Hans Olsson, Peter Söderkvist, Per Hultman, Johan Rosell and Staffan Jahnson
  MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
  BMC Urology, 2013, 13(5), .
   Fulltext  PDF  
 Web of Science® Times Cited: 12

Hans Olsson, Per Hultman, Johan Rosell and Staffan Jahnson
  Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours
  Scandinavian Journal of Urology and Nephrology, 2013, 47(3), 188-195.
 Web of Science® Times Cited: 7

Georg Jancke, Johan Rosell, Gunilla Chebil and Staffan Jahnson
  Bladder Wash Cytology at Diagnosis of Ta-T1 Bladder Cancer Is Predictive for Recurrence and Progression
  Urology, 2012, 80(3), 625-631.
 Web of Science® Times Cited: 1

Hans Olsson, Per Hultman, Nastaran Monsef, Johan Rosell and Staffan Johanson
  Immunohistochemical Evaluation of Cell Cycle Regulators: Impact on Predicting Prognosis in Stage T1 Urinary Bladder Cancer
  ISRN Urology, 2012, 2012, .
   Fulltext  PDF  

Yang-mei Shen, Gunnar Arbman, Per Sandström, Per Gullstrand, Yu-Quan Wei, Hong Zhang, Johan Rosell, Birgit Olsson, Feng Peng, Han-Shuo Yang, Chun-Ting Wang and Xiao-Feng Sun
  Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients
  Oncology Reports, 2012, 27(2), 376-382.
 Web of Science® Times Cited: 4

Georg Jancke, Johan Rosell and Staffan Jahnson
  Residual tumour in the marginal resection after a complete transurethral resection is associated with local recurrence in Ta/T1 urinary bladder cancer
  Scandinavian Journal of Urology and Nephrology, 2012, 46(5), 343-347.
 Web of Science® Times Cited: 9

Annika Malmström, Bjorn Henning Gronberg, Christine Marosi, Roger Stupp, Didier Frappaz, Henrik Schultz, Ufuk Abacioglu, Bjorn Tavelin, Benoit Lhermitte, Monika E Hegi, Johan Rosell and Roger Henriksson
  Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
  The Lancet Oncology, 2012, 13(9), 916-926.
 Web of Science® Times Cited: 422

Annika Malmström, Roger Stupp, Monika Hegi, Johan Rosell and Roger Henriksson
  Treatment options in elderly patients with glioblastoma - Authors' reply
  The Lancet Oncology, 2012, 13(11), E461-E462.

Jasmine Loof, Johan Rosell, Charlotte Bratthall, Siv Doré, Hans Starkhammar, Hong Zhang and Xiao-Feng Sun
  Impact of PINCH expression on survival in colorectal cancer patients
  BMC CANCER, 2011, 11(103), .
   Fulltext  PDF  
 Web of Science® Times Cited: 6

Georg Jancke, Johan Rosell and Staffan Jahnson
  Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder
  Scandinavian Journal of Urology and Nephrology, 2011, 45(6), 388-392.
 Web of Science® Times Cited: 9

Gabriel Sandblom, Eberhard Varenhorst, Johan Rosell, Owe Lofman and Per Carlsson
  Letter: PROSTATE CANCER SCREENING Authors reply
  BMJ. British Medical Journal, 2011, 342, .

Gabriel Sandblom, Eberhard Varenhorst, Johan Rosell, Owe Lofman and Per Carlsson
  Randomised prostate cancer screening trial: 20 year follow-up
  BRITISH MEDICAL JOURNAL, 2011, 342(d1539), .
   Fulltext  PDF  
 Web of Science® Times Cited: 76

Laszlo Tabar, Bedrich Vitak, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Anders Cohen, Tibor Tot, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, Jean Ching-Yuan Fann, Johan Rosell, Helena Fohlin, Robert A Smith and Stephen W Duffy
  Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades
  Radiology, 2011, 260(3), 658-663.
 Web of Science® Times Cited: 295

Johan Rosell, Bo Nordenskjöld, N-O Bengtsson, T Fornander, T Hatschek, H Lindman, P-O Malmstrom, A Wallgren, Olle Stål and John Carstensen
  Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial
  British Journal of Cancer, 2011, 104(6), 899-902.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Staffan Jahnson, Ole Damm, Sverker Hellsten, Sten Holmang, Fredrik Liedberg, Borje Ljungberg, Per-Uno Malmstrom, Wiking Mansson, Johan Rosell and Hans Wijkstom
  Urinary diversion after cystectomy for bladder cancer: A population-based study in Sweden
  SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2010, 44(2), 69-75.
 Web of Science® Times Cited: 8

Jingfang Gao, Gunnar Arbman, L.. He, Zhiyong Zhang, Z. Zhao, Johan Rosell and Xiao-Feng Sun
  MANBA polymorphism was related to increased risk of colorectal cancer in Swedish but not in Chinese populations
  Acta Oncologica, 2008, 47(3), 372-378.

Katja Fall, Fredrik Strömberg, Johan Rosell and Eberhard Varenhorst
  Reliability of death certificates in prostate cancer patients
  Scandinavian Journal of Urology and Nephrology, 2008, 42(4), 352-357.
 Web of Science® Times Cited: 56

Georg Jancke, Ole Damm, Johan Rosell and Staffan Jahnson
  Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer
  Scandinavian Journal of Urology and Nephrology, 2008, 42(5), 417-421.
 Web of Science® Times Cited: 4

David Robinson, Gunnar Aus, Julia Bak, Tomasz Gorecki, Anders Herder, Johan Rosell and Eberhard Varenhorst
  Long-term follow-up of conservatively managed incidental carcinoma of the prostate A multivariate analysis of prognostic factors
  Scandinavian Journal of Urology and Nephrology, 2007, 41(2), 103-109.
 Web of Science® Times Cited: 20

Bo Nordenskjöld, Johan Rosell, Lars-Erik Rutqvist, Per-Olof Malmström, Jonas Bergh, Nils-Olof Bengtsson, Thomas Hatschek, Arne Wallgren and John Carstensen
  Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: Results from a randomized trial
  Journal of the National Cancer Institute, 2005, 97(21), 1609-1610.
 Web of Science® Times Cited: 50

Gunnar Aus, David Robinson, Johan Rosell, Gabriel Sandblom and Eberhard Varenhorst
  Survival in prostate carcinoma - Outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: Results from three counties in the population-based National Prostate Cancer Registry of Sweden
  Cancer, 2005, 103(5), 943- 951.
 Web of Science® Times Cited: 39

Gabriel Sandblom, Eberhard Varenhorst, Owe Löfman, Johan Rosell and Per Carlsson
  Clinical consequences of screening for prostate cancer: 15 Years follow-up of a randomised controlled trial in Sweden
  European Urology, 2004, 46(6), 717-723.
 Web of Science® Times Cited: 62

Gunnar Aus, Kerstin Nordenskjöld, David Robinson, Johan Rosell and Eberhard Varenhorst
  Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer: A Prospective Study Based on Data from a Swedish Population-Based Cohort
  European Urology, 2003, 43(6), 627-631.
 Web of Science® Times Cited: 22

Ph.D. Theses

Johan Rosell
  Long-term effects of adjuvant tamoxifen treatment on cardiovascular disease and cancer
  2014.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.

 



Responsible for this page: Peter Berkesand
Last updated: 2010-08-30